Director, Global Commercial Strategy – GI

Director, Global Commercial Strategy – GI (Horsham, PA or Spring House, PA)
Purpose

Drive integrated commercial strategy across early discovery through late-stage development assets in the GI portfolio; embed commercial input early, shape development decisions, advance launch readiness, and maximize long-term asset/portfolio value.
Key Responsibilities

Serve as commercial lead for early-stage Compound Development Teams (CDTs); embed strategy from discovery to proof-of-concept aligned to DAS roadmap and portfolio value.
Translate DAS roadmap into asset-level strategies (disease spaces, patient segments, clinical value drivers, differentiation requirements, evidence needs).
Shape TPPs, indication sequencing, competitive positioning, and go
o-go criteria.
Provide commercial input into clinical trial design (endpoints, comparators, enrichment, line-of-therapy, label-enabling evidence).
Drive portfolio prioritization (unmet need, competitive intensity, differentiation, market access feasibility, revenue potential).
Partner to evaluate external assets, combinations, and white-space opportunities.
Develop executive-ready recommendations for governance forums.
Translate asset strategy into launch-ready commercial plans; lead late-stage commercial workstreams and pre-launch planning (positioning, evidence generation, stakeholder engagement, milestones).
Lead competitive strategy/differentiation; partner on scientific narrative/evidence and value/reimbursement; generate actionable insights with GCI.
Education/Qualifications

Bachelor’s required; advanced degree preferred (MBA, PharmD, PhD, MD, or related discipline).
10+ years progressive experience in commercial strategy/marketing/business development/market access/medical affairs/R&D strategy or related.
Experience across pipeline, early/late/launch assets (ideally immunology, gastroenterology, specialty medicine).
Strong drug development, clinical trial, regulatory, evidence generation, market access, and global commercialization knowledge.
Preferred

Ability to shape TPPs/value propositions/asset positioning/investment recommendations; lead complex global cross-functional initiatives in matrix settings.
Other

Up to 10% domestic and international travel.

#J-18808-Ljbffr